Hugh M Cole - Net Worth and Insider Trading
Hugh M Cole Net Worth
The estimated net worth of Hugh M Cole is at least $924,639 dollars as of 2024-05-05. Hugh M Cole is the SVP, Chief Business Officer of ARIAD Pharmaceuticals Inc and owns about 29,916 shares of ARIAD Pharmaceuticals Inc (ARIA) stock worth over $717,685. Hugh M Cole is also the COO of Jounce Therapeutics Inc and owns about 110,082 shares of Jounce Therapeutics Inc (JNCE) stock worth over $206,954. Details can be seen in Hugh M Cole's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Hugh M Cole has not made any transactions after 2023-01-10 and currently still holds the listed stock(s).
Transaction Summary of Hugh M Cole
Hugh M Cole Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Hugh M Cole owns 3 companies in total, including Jounce Therapeutics Inc (JNCE) , Astria Therapeutics Inc (ATXS) , and ARIAD Pharmaceuticals Inc (ARIA) .
Click here to see the complete history of Hugh M Cole’s form 4 insider trades.
Insider Ownership Summary of Hugh M Cole
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| JNCE | Jounce Therapeutics Inc | 2023-01-10 | Chief Business Officer |
| ATXS | Astria Therapeutics Inc | 2020-06-11 | director |
| ARIA | ARIAD Pharmaceuticals Inc | 2017-02-16 | SVP & Chief Business Officer |
Hugh M Cole Latest Holdings Summary
Hugh M Cole currently owns a total of 2 stocks. Among these stocks, Hugh M Cole owns 29,916 shares of ARIAD Pharmaceuticals Inc (ARIA) as of June 28, 2016, with a value of $717,685 and a weighting of 77.62%. Hugh M Cole also owns 110,082 shares of Jounce Therapeutics Inc (JNCE) as of January 10, 2023, with a value of $206,954 and a weighting of 22.38%.
Latest Holdings of Hugh M Cole
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ARIA | ARIAD Pharmaceuticals Inc | 2016-06-28 | 29,916 | 23.99 | 717,685 |
| JNCE | Jounce Therapeutics Inc | 2023-01-10 | 110,082 | 1.88 | 206,954 |
Holding Weightings of Hugh M Cole
Hugh M Cole Form 4 Trading Tracker
According to the SEC Form 4 filings, Hugh M Cole has made a total of 0 transactions in ARIAD Pharmaceuticals Inc (ARIA) over the past 5 years. The most-recent trade in ARIAD Pharmaceuticals Inc is the sale of 6,012 shares on June 28, 2016, which brought Hugh M Cole around $42,385.
According to the SEC Form 4 filings, Hugh M Cole has made a total of 7 transactions in Jounce Therapeutics Inc (JNCE) over the past 5 years, including 0 buys and 7 sells. The most-recent trade in Jounce Therapeutics Inc is the sale of 16,634 shares on January 10, 2023, which brought Hugh M Cole around $18,464.
Insider Trading History of Hugh M Cole
- 1
Hugh M Cole Trading Performance
GuruFocus tracks the stock performance after each of Hugh M Cole's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Hugh M Cole is -13.26%. GuruFocus also compares Hugh M Cole's trading performance to market benchmark return within the same time period. The performance of stocks bought by Hugh M Cole within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Hugh M Cole's insider trading performs compared to the benchmark.
Performance of Hugh M Cole
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -1.14 | | | | | |
| Relative Return to S&P 500(%) | -1.92 | | | | | |
Hugh M Cole Ownership Network
Hugh M Cole Owned Company Details
What does Jounce Therapeutics Inc do?
Who are the key executives at Jounce Therapeutics Inc?
Hugh M Cole is the Chief Business Officer of Jounce Therapeutics Inc. Other key executives at Jounce Therapeutics Inc include 10 percent owner Concentra Merger Sub, Inc. , 10 percent owner Concentra Biosciences, Llc , and director & CEO and President Richard /ca/ Murray .
Jounce Therapeutics Inc (JNCE) Insider Trades Summary
Over the past 18 months, Hugh M Cole made 1 insider transaction in Jounce Therapeutics Inc (JNCE) with a net sale of 16,634. Other recent insider transactions involving Jounce Therapeutics Inc (JNCE) include a net sale of 84,298 shares made by Richard /ca/ Murray , a net purchase of 85,987 shares made by Kevin C Tang , and a net sale of 14,096 shares made by Kimberlee C Drapkin .
In summary, during the past 3 months, insiders sold 0 shares of Jounce Therapeutics Inc (JNCE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 124,313 shares of Jounce Therapeutics Inc (JNCE) were sold and 85,987 shares were bought by its insiders, resulting in a net sale of 38,326 shares.
Jounce Therapeutics Inc (JNCE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Jounce Therapeutics Inc Insider Transactions
Hugh M Cole Mailing Address
Above is the net worth, insider trading, and ownership report for Hugh M Cole. You might contact Hugh M Cole via mailing address: C/o Ariad Pharmaceuticals, Inc, 26 Landsdowne Street, Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
